A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer
NCT03516045
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
18F-AlF-NOTA-neurotensin
Sponsor
Xiangya Hospital of Central South University